Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07017972 · ClinicalTrials.gov registry record

Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model

A clinical trial of Fertility Disorders, sponsored by Fairtility.

Recruiting
Registry status
4,000
Enrollment target
1
Study location

NCT07017972 is a study of Fertility Disorders that is actively recruiting participants, run by Fairtility. The registered enrollment target is 4,000 participants, above the 261-participant average among 3 other Fertility Disorders trials with a reported enrollment target (1433% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07017972, a study of Fertility Disorders, is actively recruiting participants, sponsored by Fairtility.

RECRUITING
Registry status
4,000 participants
Enrollment target
1
Study location

Study Summary

This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-quality real clinical data. It also aims to enhance machine learning in developmental-use AI software. In addition, the professional user simulated use will ensure correct and easy use of the AI applications.

Conditions Studied

Interventions

  • DEVICE AI evaluation of embryos

Study Locations (1)

Connecticut

  • New England Fertility Institute - Stamford

Trial Details

FieldValue
Enrollment Target 4,000 participants
Start Date 2025-06-20
Est. Completion 2027-06-20

Sponsor

Fairtility

4 total trials

What the Registry Record Tells You About NCT07017972

The ClinicalTrials.gov registry entry for NCT07017972 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 261-participant average among 3 other Fertility Disorders trials with a reported enrollment target (1433% higher). The listed sponsor is Fairtility, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fertility Disorders appearing as the primary indexed condition, and to 1 intervention - of which AI evaluation of embryos is the first listed.

NCT07017972 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT07017972 about?

NCT07017972 is a clinical study titled "Data Collection and Professional Simulated Use Study to Develop an Embryo Quality Artificial Intelligence (AI) Model". This protocol supports the reliable development and improvement of Artificial Intelligence (AI)-based applications by enabling training, verification, and validation using high-quality real clinical data. It also aims to enhance machine learning in developmental-use AI software. In addition, the pr...

What is the current status of trial NCT07017972?

This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2025-06-20. Estimated completion is 2027-06-20.

What conditions does trial NCT07017972 study?

This clinical trial studies the following conditions: Fertility Disorders.

What interventions are being tested in trial NCT07017972?

The interventions under investigation include: AI evaluation of embryos (DEVICE).

Who is sponsoring clinical trial NCT07017972?

This trial is sponsored by Fairtility, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07017972 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fertility Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.